Modified serpinA1 as risk marker for Parkinson's disease dementia: Analysis of baseline data.
about
Naturally Occurring Autoantibodies against Tau Protein Are Reduced in Parkinson's Disease Dementia.Accuracy Improvement for Predicting Parkinson's Disease Progression.Proteomic studies in the discovery of cerebrospinal fluid biomarkers for amyotrophic lateral sclerosis.Genetics of early-onset Parkinson's disease in Finland: exome sequencing and genome-wide association study.Diagnostic utility of cerebrospinal fluid α-synuclein in Parkinson's disease: A systematic review and meta-analysis.
P2860
Modified serpinA1 as risk marker for Parkinson's disease dementia: Analysis of baseline data.
description
2016 nî lūn-bûn
@nan
2016 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Modified serpinA1 as risk mark ...... ia: Analysis of baseline data.
@ast
Modified serpinA1 as risk mark ...... ia: Analysis of baseline data.
@en
type
label
Modified serpinA1 as risk mark ...... ia: Analysis of baseline data.
@ast
Modified serpinA1 as risk mark ...... ia: Analysis of baseline data.
@en
prefLabel
Modified serpinA1 as risk mark ...... ia: Analysis of baseline data.
@ast
Modified serpinA1 as risk mark ...... ia: Analysis of baseline data.
@en
P2093
P2860
P50
P356
P1433
P1476
Modified serpinA1 as risk mark ...... ia: Analysis of baseline data.
@en
P2093
Elmar Pinkhardt
Hans Klafki
Jens Wiltfang
Magdalena Nagl
Markus Otto
Petra Steinacker
Steffen Halbgebauer
Ute Haußmann
P2860
P2888
P356
10.1038/SREP26145
P407
P577
2016-05-17T00:00:00Z
P6179
1000061913